Ocular Melanoma
- PMID: 31869111
- Bookshelf ID: NBK551647
Ocular Melanoma
Excerpt
Melanoma, marked by the malignant overgrowth of melanocytes, encompasses ocular melanoma, the second most prevalent type after cutaneous melanoma and the most common primary intraocular malignant tumor in adults. Approximately 85% originate in the uveal tract, including the iris, ciliary body, and choroid, with most emerging from the ciliary body or choroid. Melanoma can also arise from the melanocytes in the epithelium of the conjunctival membrane, accounting for less than 10% of ocular melanomas.
The risk is most significant in patients with light-colored irises and is further influenced by factors such as sunlight exposure, genetic predisposition, and underlying illnesses. Ocular melanoma can be diagnosed incidentally through funduscopic examination or when patients present with various visual symptoms such as decreased visual acuity, scotoma, visual field loss, ocular pain, or floaters. Diagnostic tools include ultrasound, optical coherence tomography, and fluorescein angiography. A small percentage of patients require a diagnostic biopsy.
Although localized interventions successfully deter relapse, nearly half of individuals with uveal tumors encounter potential metastatic progression due to early micrometastatic occurrences. Ocular melanoma commonly disseminates hematogenously, with the liver being a primary target. The overall prognosis depends on factors such as tumor size, location, and histologic traits. Importantly, the selection of local treatment does not impact long-term survival outcomes.
Copyright © 2024, StatPearls Publishing LLC.
Conflict of interest statement
Sections
- Continuing Education Activity
- Introduction
- Etiology
- Epidemiology
- Pathophysiology
- Histopathology
- History and Physical
- Evaluation
- Treatment / Management
- Differential Diagnosis
- Staging
- Prognosis
- Complications
- Consultations
- Deterrence and Patient Education
- Enhancing Healthcare Team Outcomes
- Review Questions
- References
Similar articles
-
[Ocular melanomas : An update].Pathologe. 2017 Nov;38(6):491-499. doi: 10.1007/s00292-017-0389-3. Pathologe. 2017. PMID: 29038913 Review. German.
-
Uveal Melanoma: Current Trends in Diagnosis and Management.Turk J Ophthalmol. 2016 Jun;46(3):123-137. doi: 10.4274/tjo.37431. Epub 2016 Jun 6. Turk J Ophthalmol. 2016. PMID: 27800275 Free PMC article. Review.
-
Ocular melanoma: an overview of the current status.Int J Clin Exp Pathol. 2013 Jun 15;6(7):1230-44. Print 2013. Int J Clin Exp Pathol. 2013. PMID: 23826405 Free PMC article. Review.
-
Uveal and conjunctival malignant melanoma in denmark 1943-97: observed and relative survival of patients followed through 2002.Ophthalmic Epidemiol. 2006 Apr;13(2):85-96. doi: 10.1080/09286580600553330. Ophthalmic Epidemiol. 2006. PMID: 16581612
-
Photobiology of ocular melanocytes and melanoma.Photochem Photobiol. 2005 May-Jun;81(3):506-9. doi: 10.1562/2004-08-24-IR-289. Photochem Photobiol. 2005. PMID: 15496134 Review.
References
-
- Nayman T, Bostan C, Logan P, Burnier MN. Uveal Melanoma Risk Factors: A Systematic Review of Meta-Analyses. Curr Eye Res. 2017 Aug;42(8):1085-1093. - PubMed
-
- Thomsen H, Chattopadhyay S, Hoffmann P, Nöthen MM, Kalirai H, Coupland SE, Jonas JB, Hemminki K, Försti A. Genome-wide study on uveal melanoma patients finds association to DNA repair gene TDP1. Melanoma Res. 2020 Apr;30(2):166-172. - PubMed
-
- Scholes AG, Damato BE, Nunn J, Hiscott P, Grierson I, Field JK. Monosomy 3 in uveal melanoma: correlation with clinical and histologic predictors of survival. Invest Ophthalmol Vis Sci. 2003 Mar;44(3):1008-11. - PubMed
Publication types
LinkOut - more resources
Full Text Sources